Guangzhou Concord Cancer Center
Comment: Why is this hospital notable? 🇵🇸🇺🇦 FiddleTimtrent FaddleTalk to me 🇺🇦🇵🇸 13:36, 2 September 2026 (UTC)
- Comment: In accordance with the Wikimedia Foundation's Terms of Use, I disclose that I have been paid by my employer for my contributions to this article. Scarlett716 (talk) 08:06, 14 August 2026 (UTC)
| Guangzhou Concord Cancer Center | |
|---|---|
| Lua error in Module:Infobox_mapframe at line 118: attempt to index field 'wikibase' (a nil value). | |
| Geography | |
| Location | Huangpu District, Guangzhou, Guangdong, China |
| Organisation | |
| Hospital type | Specialist |
| Services | |
| Speciality | Oncology |
| Links | |
| Website | www |
Guangzhou Concord Cancer Center (GCCC) is a private oncology hospital in Guangzhou, Guangdong, China. It provides cancer prevention, screening, diagnosis, treatment and rehabilitation services.[1][2]
The hospital opened in June 2021 following an agreement between Concord Healthcare Group and a public cancer center in Guangzhou.[1][3] Its proton therapy center began full-scale operations in December 2024.[4]
History
An agreement to establish the hospital was reached in 2010 between Concord Healthcare Group and a public cancer center in Guangzhou.[3]
Installation of the proton therapy facility included an accelerator, rotating gantries, beamline magnets, equipment cabinets and treatment couches.[5] The facility has four gantry rooms.[6]
GCCC is a full member of the Union for International Cancer Control.[1]
In May 2024, the hospital received the "Third Session China Good Hospital Construction Demonstration Award" (第三届中国美好医院建设示范奖) at the 2024 China Hospital Construction Conference awards ceremony.[7]
In December 2025, the center was designated as one of 27 additional medical institutions under a Guangdong–Hong Kong–Macao Greater Bay Area program. Under the program, designated hospitals may use drugs and medical devices approved in Hong Kong and Macao.[8]
Proton therapy
The center uses a Varian ProBeam proton therapy system. Installation and commissioning were carried out during the COVID-19 pandemic.[6]
The proton therapy center began full-scale operations in December 2024 and treated its 1,000th patient in July 2026.[4]
Research
In 2024, researchers affiliated with the center co-authored a study on a GPU-accelerated Monte Carlo dose engine for pencil-beam scanning proton therapy and a consensus paper on proton stereotactic body and hypofractionated radiotherapy for thoracic malignancies.[9][10]
References
- ↑ 1.0 1.1 1.2 "Guangzhou Concord Cancer Center (GCCC)". Union for International Cancer Control. Retrieved 17 August 2026.
- ↑ "Proton Therapy and Advanced Cancer Care in China". Guangzhou Concord Cancer Center. Retrieved 17 August 2026.
- ↑ 3.0 3.1 Li, Wenfang (28 June 2023). "Guangzhou cancer center epitomizes reform push". China Daily. Retrieved 17 August 2026.
- ↑ 4.0 4.1 Li, Jing; Li, Wenfang (31 July 2026). "Concord rides nation's private healthcare push to robust growth". China Daily. Retrieved 17 August 2026.
- ↑ "广州泰和肿瘤医院质子治疗设备的安装 [Installation of Proton Therapy Equipment in Guangzhou Taihe Cancer Hospital]". 中国医院建筑与装备 (in 中文). 23 (9). Retrieved 17 August 2026.
- ↑ 6.0 6.1 Shen, Li; Li, Zuofeng; Yuan, Xiaogang; Liu, Shengwen; Xie, Qishan; Li, Shu; Liu, Bing; Yu, Yue (2022). "The COVID-19 pandemic impacts to proton therapy system installation and commissioning". International Journal of Particle Therapy. 9 (3): 58–242. doi:10.14338/IJPT-22-PTCOG59-9.3. PMC 9875827 Check
|pmc=value (help). - ↑ Interim Report 2024 (PDF) (Report). Concord Healthcare Group Co., Ltd. 29 August 2024. Retrieved 17 August 2026 – via Hong Kong Exchanges and Clearing.
- ↑ Li, Bingcun (9 December 2025). "27 more mainland medical facilities allowed to use drugs, devices from HK, Macao". China Daily Hong Kong. Retrieved 17 August 2026.
- ↑ Feng, Hongying; Holmes, Jason M.; Vora, Sujay A.; et al. (17 January 2024). "Modelling small block aperture in an in-house developed GPU-accelerated Monte Carlo-based dose engine for pencil beam scanning proton therapy". Physics in Medicine & Biology. 69 (3). doi:10.1088/1361-6560/ad0b64. PMC 11009986 Check
|pmc=value (help). PMID 37944480 Check|pmid=value (help). - ↑ Liu, Wei; Feng, Hongying; Taylor, Paige A.; et al. (15 July 2024). "NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies". International Journal of Radiation Oncology, Biology, Physics. 119 (4): 1208–1221. doi:10.1016/j.ijrobp.2024.01.216. PMC 11209785 Check
|pmc=value (help). PMID 38395086 Check|pmid=value (help).
External links
This article "Guangzhou Concord Cancer Center" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Guangzhou Concord Cancer Center. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
